Cryoport, Inc. (CYRX) stock
CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/3025% above fair value
$19.89−0.21 (-1.04%)
Close on Nov 13, 2026Market cap $1.01BP/E –Yield –
Cryoport enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cryoport's enterprise value was $645.62M on Nov 11, 2026, against $61.64M a year earlier. Over the last 5 years it ranged from -$106.87M to $2.39B, with a median of $292.89M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $645.62M | +964.7% |
| 2025 | Dec 31, 2025 | $60.64M | -46.4% |
| 2024 | Dec 31, 2024 | $113.14M | -61.4% |
| 2023 | Dec 29, 2023 | $292.89M | -6.5% |
| 2022 | Dec 30, 2022 | $313.31M | -86.9% |
| 2021 | Dec 31, 2021 | $2.39B | +58.5% |
| 2020 | Dec 31, 2020 | $1.51B | +203.7% |
| 2019 | Dec 31, 2019 | $496.48M | +66.3% |
| 2018 | Dec 31, 2018 | $298.49M | +191.4% |
| 2017 | Dec 29, 2017 | $102.45M | +177.6% |
| 2016 | Dec 30, 2016 | $36.90M | +397.0% |
| 2015 | Dec 31, 2015 | $7.42M | -71.8% |
| 2014 | Dec 31, 2014 | $26.32M | +45.6% |
| 2013 | Dec 31, 2013 | $18.07M | +42.5% |
| 2012 | Dec 31, 2012 | $12.68M | -10.6% |
| 2011 | Dec 30, 2011 | $14.18M | – |
See a number that looks wrong?